Dr. Jeffrey Ewing Lee, MD

Dr. Lee practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Lee's NPI, 1801943279, was assigned on January 5, 2007. Dr. Lee graduated from University of California San Diego School of Medicine in 2005. Dr. Lee holds California license A97291.

Dr. Lee's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Lee's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Lee is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health. Dmand AI also links Dr. Lee to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lee practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Lee's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Lee is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Lee's licenses on file in 2 states: California and Wisconsin.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Lee treats.

CMS data shows 1,181 Medicare services from Dr. Lee across 14 procedure codes in 2024, for 628 Medicare patients. Medicare paid $146,391 for them.

CMS counts 628 Medicare patients who saw Dr. Lee in 2024. The largest group is 65 to 74, with 271 patients. 71% of them have high cholesterol, and 64% have high blood pressure. 35% are also on Medicaid. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lee's median patient age at 65, with 57% women.

In 2024, Dr. Lee wrote 472 Medicare Part D claims for 179 patients. 29% of them were for generic drugs. CMS names the drug for 406 of them, across 9 drugs with 11 or more claims each, at $88,391 in total drug cost. In 2023, CMS named 259 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Lee for performance year 2024, reported as part of a group. Dr. Lee accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 149 procedures of cataract surgery by Dr. Lee, more than 80% of the clinicians it reports for that procedure.

Dmand AI links 7 papers to Dr. Lee, published from 2018 to 2020. 2018 was the busiest year, with 2. The most frequent topics are Ophthalmology, Documentation and Electronic Health Records. Dr. Lee has published most often in J Acad Ophthalmol (2017). Dr. Lee's most frequent co-authors are Sally Liu Baxter, MD, Andrew S. Camp, MD and Robert E. El-Kareh, MD.

CMS Open Payments shows 63 general payments to Dr. Lee from 13 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 53% of the total. Alcon Laboratories Inc paid the most, $2,936.

Dr. Lee graduated from University of California San Diego School of Medicine in 2005.

Dr. Lee is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.